Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Shopify Inc. — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B), while Shopify Inc. trades at $170.62 (market cap $211.73B). The key difference: Shopify Inc. is far larger — about 8.4× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Shopify Inc. for 78 Days on average.
| RPRX | SHOP | |
|---|---|---|
Market Cap | $25.27B | $211.73B |
Volume | 3,671,183 | 7,146,651 |
Sector | Health | Technology |
52-Week High | $63.96 | $179.01 |
52-Week Low | $35.44 | $95.40 |
Typical Hold Time | 1 Days | 78 Days |
Enterprise Value | $32.50B | $206.96B |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Shopify (SHOP) trades at $170.85, up 2.96% today, showing strong momentum near its 52-week high. The stock exhibits bullish technical signals with positive moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, Shopify demonstrates robust revenue growth from $5.6B in 2022 to $11.6B in 2025, with net income turning positive and reaching $1.23B. Recent earnings show mixed results with one miss and two beats in the last three quarters.
Shopify's outlook remains positive with accelerating merchant solutions growth and AI innovations, though elevated valuation metrics (P/E of 111.19) present risk. Analyst consensus is strongly bullish with 67% buy ratings and $168.63 price target. Key risks include competitive pressures from Amazon and valuation sensitivity to growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
